While President Donald Trump appears to have signaled a relaxing of his previously stated plan to introduce significant tariffs (of up to 100%) on imported pharmaceuticals, as Axios noted, the reality is that drug shortages remain a very real thing — and the mercurial nature of contemporary tariff policy means that shortages could once again threaten many prescription holders in the near or immediate future.
Should you end up facing a shortage in your medications due to tariffs, or for other market-related availability issues, what should you do?
